Literature DB >> 15110215

Effects of race on lipid-lowering management in hospitalized patients with coronary heart disease.

Daniel D Dressler1, Terry A Jacobson.   

Abstract

The objective of this study was to determine the association between patient characteristics, specifically race, and the appropriate management of lipid-reducing therapy in patients with coronary heart disease (CHD) discharged from the hospital. Two hundred fifty-eight consecutive patients with diagnoses suggestive of CHD were identified in a large, inner-city university teaching hospital serving a predominantly indigent African American population. The outcome measure, suboptimal lipid management, evaluated the intensification of lipid-reducing therapy when indicated using the National Cholesterol Education Program guidelines for the low-density lipoprotein cholesterol goal. The overall rate of suboptimal lipid management was 48%. Black patients with CHD were significantly more likely to have suboptimal lipid management than nonblack patients by the time of hospital discharge (52.3% vs 16.7%, p = 0.021). The disparity in the clinical management of black patients with CHD may help explain the differential in health outcomes seen between black and white patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15110215     DOI: 10.1016/j.amjcard.2004.01.052

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  2 in total

1.  Patient race/ethnicity and patient-physician race/ethnicity concordance in the management of cardiovascular disease risk factors for patients with diabetes.

Authors:  Ana H Traylor; Usha Subramanian; Connie S Uratsu; Carol M Mangione; Joe V Selby; Julie A Schmittdiel
Journal:  Diabetes Care       Date:  2009-12-15       Impact factor: 17.152

2.  Disparities in lipid management for African Americans and Caucasians with coronary artery disease: a national cross-sectional study.

Authors:  Mark W Massing; Kathleen A Foley; Lori Carter-Edwards; Carla A Sueta; Charles M Alexander; Ross J Simpson
Journal:  BMC Cardiovasc Disord       Date:  2004-08-18       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.